Campaign: Artists draw hearts to encourage U.K. residents to be organ donors
The project, called Heart at Home, is raising awareness as the U.K. changes its organ donation system to an opt-out policy.
The project, called Heart at Home, is raising awareness as the U.K. changes its organ donation system to an opt-out policy.
Tara Powers is VP, creative director at Elevate Healthcare.
Two makers of health apps walked away with the top prizes and access to more from the drugmaker.
Utah Senator who backed Orphan Drug Act will not seek reelection; medicines more expensive in 2018; Spark’s genetic therapy for rare blindness costs $850,000
Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients
Novartis’ heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron’s Xadago for PD
The first two PCSK9s landed with a thud. What does their disappointing launch say about the need for marketers of CV drugs to get their pricing houses in order?
Novartis’ Entresto and Cosentyx miss sales forecasts; faith-based investor group urges pricing transparency; Amgen invests in digital health
One oft-cited challenge to Entresto’s adoption has been prior authorization requirements.
The new company, iBeat, plans to market a wearable device that can detect the symptoms of cardiac arrest and heart attacks.